N/A N=35 Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy
Pain · Hysterectomy · Myomectomy
Primary: Quality of Surgical Field Visualization — 9; 1; 5; 2 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=444 Brief Online Interventions for Alcohol Use
Alcohol Use Disorder
Primary: Alcohol Use — 19.4; 16.3; 15.3; 19.1 percentage heavy drinking days
N/A N=6 Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Catecholaminergic Polymorphic Ventricular Tachycardia
Primary: Number of Ventricular Ectopic Beats Recorded During Exercise (and Recovery) — 46; 0 number of ventricular beats
N/A N=40 Dietary Treatment Study of Pediatric NAFLD
Nonalcoholic Fatty Liver Disease
Primary: Change in Percentage of Liver Fat Measured by Magnetic Resonance Imaging (MRI) in the Intervention Group Compared to Change in the Control Group — 22.9; 19.4; 14.9; 18.0…
N/A N=10 Prone Breast Irradiation for Pendulous Breasts
Breast Cancer
Primary: Dose Homogeneity 1: PTV — 9.8; 8.2; 48.2; 49.8 Gy — p=<0.05
N/A N=60 Is Univalving or Bivalving of Long Arm Casts for Forearm Fractures Necessary?
Fracture of Shaft of Radius and/or Ulna · Metaphyseal Fracture of Bone of Upper Limb · Fracture of Upper Limb, Level Unspecified
Primary: Complication Rate of the Cast Type — 9; 12; 8 participants
Phase 3 N=39 Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation
Optic, Atrophy, Hereditary, Leber
Primary: Change From Baseline in ETDRS Visual Acuity (Quantitative Score) at Week 48 — 0.380; 0.392 LogMAR — p=0.8890
N/A N=254 Frozen Red Blood Cell Transfusions in Trauma Patients
Blood Loss · Anemia · Trauma
Primary: Tissue Oxygenation — 100.3; 98.2; 98.3 percentage of baseline
N/A N=27 Effects of Mild Hypoglycaemia on Cognitive Function in Type 2 Diabetes
Diabetes Mellitus, Type II · Hypoglycemia · Cognitive Change
Primary: Psychomotor Speed — 48.7; 56.6 score on a scale
Phase 2 N=75 A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Non-Alcoholic Steatohepatitis
Primary: Mean Change in Percent Hepatic Fat Fraction (%) by Magnetic Resonance Imaging (MRI) From Baseline to Week 16 — -8.43; -6.45; -1.26; -6.77 percentage — p=0.0004
N/A N=21 Translational Research Examining Acupuncture Treatment in Traumatic Brain Injury
Traumatic Brain Injury
Primary: Cerebral Blood Flow Velocity in the Left (L) and Right (R) Middle Cerebral Artery (MCA), Internal Carotid Artery (ICA), and Basilar Artery (BA). — 3.2; 6.7; 4; 12.7 ml/sec
N/A N=18 Effects of Reading to Preterm Infants on Baby and Parents' Well Being
Parental Infant Bonding · Cardio-respiratory Stability in Preterm NICU Infants
Primary: Percent of Oxygen Saturation Measurements <85% — 15.2; 16.94; 17.65; 14.39 Percent Oxygen saturation measurements
N/A N=64 Evaluation of a CarePartner-Integrated Telehealth Rehabilitation Program for Persons With Stroke
Stroke
Primary: Wolf Motor Function Test (WMFT) — 12.83; 9.38; 9.73; 4.70 seconds
Phase 2 N=70 A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8
Hyperkalemia
Primary: Mean Absolute Change in S-K From Baseline Until 4h After Start of Dosing With SZC/Placebo — -0.41; -0.27 mmol/L
Phase 2 N=66 Ruxolitinib (INCB018424) in Participants With Primary Myelofibrosis (PMF), Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis (PPV-MF)
MPN (Myeloproliferative Neoplasms)
Primary: Percent Change From Baseline in Spleen Volume at Week 24 by Final Titrated Dose — -11.6; -17.4; -22.4; -13.4 Percentage change from baseline — p=0.0250